Location History:
- Joinville Le Pont, FR (1991 - 1993)
- Biberonne, FR (2002)
- F 77410 Claye-Souilly, FR (2003)
- Souilly, FR (2001 - 2004)
- Clave Souilly, FR (2004 - 2006)
- Claye-Souilly, FR (1996 - 2008)
Company Filing History:
6 out of 377 
4 out of 854 
1 out of 6,662 
Years Active: 1991-2008
Title: Jean-Francois Gourvest: An Innovative Mind in the Field of Medicinal Chemistry
Introduction:
Jean-Francois Gourvest, a resident of Claye Souilly, France, is a prominent name in the world of medicinal chemistry. With an impressive track record of 34 patents, Gourvest has made significant contributions to the development of pharmaceutical compounds with diverse applications. In this article, we delve into his latest patents, career highlights, collaborations, and the impact of his work.
Latest Patents:
Gourvest's recent patents showcase his expertise in developing novel compounds with potential therapeutic applications. Two notable inventions are "Cycloalkyl derivatives as inhibitors of bone resorption and vitronectin receptor antagonists" and "Hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives, combinatorial libraries containing same, pharmaceutical compositions containing same and methods of preparation."
The first patent describes cycloalkyl derivatives that act as medications to inhibit bone resorption and antagonize vitronectin receptors. Bone resorption inhibitors play a crucial role in treating conditions such as osteoporosis and related bone disorders, while vitronectin receptor antagonists have potential use in cancer therapy.
The second patent focuses on hexahydropyridazine-3-carboxylic acid hydrazide and hydrazone derivatives. These compounds exhibit a dual mechanism of action, inhibiting both proteases and kinases. They hold promise for the treatment of cardiovascular diseases, central nervous system disorders, inflammatory conditions, bone diseases, infectious diseases, and certain cancers.
Career Highlights:
Gourvest's extensive patent portfolio demonstrates his dedication and expertise in medicinal chemistry. Throughout his career, he has played a vital role in advancing the field and has worked with renowned companies such as Others (formerly known as InterMune) and Aventis Pharma S.A. His contributions have significantly impacted the development of innovative therapies and pharmaceutical products.
Collaborations:
Collaboration plays a crucial role in the field of research and innovation, and Gourvest has been no exception. Noteworthy collaborations include his work alongside colleagues Jochen Knolle and Denis Carniato. These partnerships have fostered the exchange of ideas, resources, and expertise, ultimately leading to groundbreaking inventions and advancements in the field.
Conclusion:
Jean-Francois Gourvest's remarkable career in medicinal chemistry and his impressive patent portfolio highlight his commitment to innovation and development. His latest patents demonstrate his ability to create novel compounds with potential therapeutic applications, particularly in the areas of bone resorption inhibitors, vitronectin receptor antagonists, and dual-action compounds for various diseases. Gourvest's collaborations have further contributed to his success, enabling the exchange of knowledge and propelling advancements in the field. We look forward to witnessing more achievements from this exceptional inventor in the years to come.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.